Here you find Ad-hoc messages of year 2011.
Investor News issued in year 2011 can be found here.
Publications of the previous years are offered in the Archive Overview.
To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.
2011 | |
|---|---|
September 29, 2011 | Phase III Study of Bayer’s Rivaroxaban in Patients with Acute Coronary Syndrome Meets Primary Efficacy Endpoint |
September 6, 2011 | Bayer AG: FDA has published documents for discussion at the Advisory Committee on the new drug application for Rivaroxaban |
You are leaving the Bayer AG website.
Bayer AG is not responsible for the information on the website to which you are linking.
collect